Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2753 of 5804
-
Internet therapy for ADHD: a new way to cope?
Symptom relief Recruiting nowAttention deficit hyperactivity disorder (ADHD) is a disorder characterized by lack of attention, hyperactivity, and impulsivity. It can have major impact on everyday life and result in negative consequences for one's personal, academic, and work situation. For individuals with s…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 26, 2026 13:01 UTC
-
New drug combo hopes to improve myelofibrosis treatment
Disease control Recruiting nowThe study is being done to see if the combination of ruxolitinib and abemaciclib is a safe and effective treatment for people with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Online CBT shows promise for teens with bulimia and higher weight
Symptom relief CompletedThis study will test the feasibility and acceptability of two treatments for adolescents with higher weight seeking treatment for bulimia nervosa (binge eating and purging, or going to extremes to lose weight).
Phase: NA • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Experimental cell therapy for tough blood cancers put on hold
Disease control TerminatedELiPSE-1 is a Phase 1, multi-center, dose-finding study to evaluate the safety, pharmacokinetics, and preliminary efficacy of CNTY-101 in participants with relapsed or refractory cluster of differentiation (CD)19-positive B-cell malignancies.
Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can an AI voice coach ease depression? new study tests lumen
Symptom relief CompletedApproximately 200 Participants with mild-to-moderate, untreated depression and/or anxiety will be randomly assigned (by chance, like flipping a coin) to 1 of 3 study groups: Lumen Coached Problem-Solving Treatment (PST) (n=100), Human Coached PST (n=50), and optional (delayed) Lu…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Can coaching parents boost social skills in kids with down syndrome?
Symptom relief CompletedIn this study, investigators will study the impact of a 1:1 caregiver coaching intervention using the JASPER (Joint Attention, Symbolic Play, Engagement, Regulation) behavioral therapy curriculum compared to a psychoeducational curriculum that will be provided to caregivers for s…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could air pollution before birth raise ADHD risk? new brain scan study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study seeks to understand the relationship between prenatal maternal air pollution exposure and offspring risk for ADHD and examine two potential -modifiable- mechanisms: prenatal maternal inflammation and offspring sleep problems. We will employ a longitudinal neuroimaging …
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Can a smartphone app ease the burden of chronic GVHD?
Symptom relief OngoingThe purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life, symptom burden, psychological distress, and coping in patients living with chronic graft-versus host disease (GVHD)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Blue dye may shield bladder in dangerous placenta surgeries
Disease control CompletedThis prospective cohort study aims to evaluate whether preoperative bladder filling with methylene blue dye can reduce the incidence of urinary tract injuries during cesarean hysterectomy in patients diagnosed with placenta accreta spectrum. A total of 60 patients will be randoml…
Phase: NA • Sponsor: Usama Ahmed Elsaeed Salem, MD • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Nerve block may offer better relief for frozen shoulder than standard joint injection
Symptom relief CompletedObjectives: In this study, we aimed to compare the efficacy of ultrasonography-guided suprascapular nerve block and intra-articular shoulder injection treatment in terms of joint range of motion, pain and functional status in patients with adhesive capsulitis (AC). Patients and …
Phase: NA • Sponsor: Hitit University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Berry boost: blackcurrant supplement linked to big strength gains in Gym-Goers
Symptom relief CompletedNew Zealand blackcurrant (NZBC) is a supplement made from a berry naturally rich in plant compounds called anthocyanins. Researchers have studied these compounds for years and found that they may help the body by improving blood flow, reducing post-exercise stress on the body, an…
Phase: NA • Sponsor: Jacksonville State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New program aims to fight Cancer-Related weight loss with exercise and diet
Symptom relief OngoingThe goal of this randomized clinical trial is to evaluate the efficacy of a self-management support program combining exercise and nutrition intervention for lung cancer patients with cancer cachexia anorexia syndrome. This study is conducted in two stages. In the first stage (P…
Phase: NA • Sponsor: Changhua Christian Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New imaging agent could spot esophagus disease without biopsy
Diagnosis CompletedAn open-label phase 2 study to assess the safety and exploratory diagnostic performance of the oral radiopharmaceutical agent NDX-3315 and NDX-3324 in healthy participants and patients with eosinophilic esophagitis (EoE).
Phase: PHASE2 • Sponsor: NexEos Diagnostics, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Could adjusting lung pressure during spine surgery prevent dangerous blood pressure drops?
Knowledge-focused CompletedThe genu pectoral position is a surgical position used for spine surgery. This surgical position will lead to physiological hemodynamic and respiratory changes during the procedure. The knee-pectoral position notably induces an increase in CRF and improves pulmonary ventilation/…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Exercise and diet tested for chemo nerve damage – but study halted early
Symptom relief TerminatedChemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and severe side-effect of platinum-based chemotherapy, often used to treat gastrointestinal cancers. Unfortunately there are very limited treatments for CIPN. This is a phase II randomized controlled trial to…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Can video calls replace clinic visits for cancer pain?
Symptom relief CompletedCancer is the second leading cause of death worldwide, with approximately 18.1 million new cases and 9.6 million deaths reported in 2018. Cancer-related pain is experienced by 50-70% of patients, with a higher prevalence at advanced disease stages (66.4%). Since the development o…
Phase: NA • Sponsor: Mahidol University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Social media support groups may ease loneliness in fibromyalgia
Symptom relief CompletedPatients suffering from fibromyalgia commonly experience depressive symptoms such as loneliness and hopelessness due to the nebulousness of the disease. A primary purpose of social media is to promote connectedness, which is associated with improved well-being. Using archival, de…
Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Real-World study checks if benralizumab tames severe asthma in taiwan
Disease control CompletedAn open-label, single-arm, non-interventional, prospective, multicenter study involving primary data collection within real-world settings for patients who receive benralizumab for treatment of severe uncontrolled eosinophilic asthma
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a liver drug tame polyps in rare gut condition?
Disease control TerminatedThis phase IIa trial investigates if giving obeticholic acid (OCA) is safe and has a beneficial effect on the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is a rare gene defect that increases the risk of developing cance…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Smart sensor could catch pneumonia early in High-Risk patients
Diagnosis Recruiting nowThis proposed research aims to evaluate the feasibility of the piezoelectric sensor as an aid to help clinicians screen for the development of pneumonia in an at-risk population.
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC